Procarbazine Capsule

Price 10 USD ($)/ Box

Get a Price/Quote

MOQ : 100 Boxes

Procarbazine Capsule Specification

Indication
Hodgkins lymphoma, certain brain tumors

Salt Composition
Procarbazine Hydrochloride

Dosage Form
Capsule

Feature
Oral administration, cytostatic activity

Ingredients
Procarbazine Hydrochloride, Excipients

Application
Antineoplastic agent used in cancer treatment

Physical Color/Texture
Opaque hard gelatin capsule

Fermentation Smell
Odorless or faint pharmaceutical odor

Storage Instructions
Cool & Dry Place

Shelf Life
2 years

Caution
Keep out of reach of children

Strength
50 mg capsule

Route of Administration
Oral

Regulatory Status
WHO GMP Certified

Packaging Size
10 capsules per blister pack

ATC Code
L01XB01

Container Type
Blister pack or bottle

Prescription Status
Prescription Only

Procarbazine Capsule Trade Information

Minimum Order Quantity
100 Boxes

FOB Port
Mundra Port, Nhava Sheva

Supply Ability
100000 Boxes Per Month

Delivery Time
7-10 Days

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
As Per Buyer Requirements

About Procarbazine Capsule

We are leading exporter and manufacturer of Procarbazine Capsule.

Uses
Procarbazine is used in the treatment of Hodgkins disease
How it works
Procarbazine belongs to a group of medicines called antineoplastic alkylating agents. It works by inhibiting protein, RNA, and DNA synthesis, which helps to stop the growth of cancer cells in the body.
Common side effects
Nausea, Vomiting, Decreased appetite

Procarbazine Capsule exporter, Procarbazine Capsule manufacturer

Procarbazine Capsule supplier, Procarbazine Capsule manufacturer in India,

Procarbazine Capsule exporter in India.

Efficient Cancer Therapy

Procarbazine capsules deliver a powerful antineoplastic effect, helping slow the progression of cancers like Hodgkins lymphoma. The medication disrupts cancer cell functions, supporting favorable outcomes when used as part of combination regimens in cancer care.

Quality and Compliance

Manufactured in India adhering to WHO GMP certification, these capsules ensure standardized quality, safety, and efficacy. Procarbazine capsules offer consistency and peace of mind for both healthcare providers and patients worldwide.

Reliable Packaging and Storage

Presented in user-friendly blister packs or bottles, Procarbazine capsules are convenient for dispensing and preservation. Storing the product in a cool, dry place maintains its stability and the 2-year shelf life as labeled on the packaging.

FAQs of Procarbazine Capsule:

Q: How should Procarbazine 50 mg capsules be taken?

A: Procarbazine capsules are intended for oral administration. Take them as prescribed by your doctor, usually as part of a combination chemotherapy regimen. Swallow each capsule whole with water, and do not open or crush them.

Q: What conditions are treated with Procarbazine capsules?

A: Procarbazine is used primarily to treat Hodgkins lymphoma and certain types of brain tumors. It acts as a cytostatic agent, meaning it inhibits the growth of cancer cells in these conditions.

Q: When is Procarbazine prescribed during cancer treatment?

A: Your physician may prescribe Procarbazine as part of a comprehensive chemotherapy protocol, often in combination with other anticancer drugs, at specific stages of treating Hodgkins lymphoma or brain tumors.

Q: Where should Procarbazine capsules be stored?

A: Store the capsules in a cool, dry place, away from direct sunlight and moisture. Always keep them out of the reach of children to ensure safety.

Q: What is the process for obtaining Procarbazine capsules?

A: Procarbazine is a prescription-only medication. You must consult an oncologist or qualified healthcare provider, who will evaluate your condition and prescribe the appropriate dosage and regimen.

Q: What are the key benefits of using Procarbazine in cancer therapy?

A: The main benefit of Procarbazine is its cytostatic activityit helps halt the division and growth of malignant cells, contributing to improved treatment outcomes in combination chemotherapy for eligible cancers.

Tell us about your requirement